Skip to main content
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children's Oncology Group.
Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation.
Application of a radiosensitivity flow assay in a patient with DNA ligase 4 deficiency.
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabine.
The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia.
Neurologic event-free survival demonstrates a benefit for SCID patients diagnosed by newborn screening.